Genentech (Record no. 240906)

MARC details
000 -LEADER
fixed length control field 02306nam a22002177a 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260214091842.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 260214b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 97802260475511
040 ## - CATALOGING SOURCE
Transcribing agency AL
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 338.76
Item number HUGG
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Sally Smith Hughes
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 254894
245 ## - TITLE STATEMENT
Title Genentech
Remainder of title : the beginnings of biotech
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Chicago
Name of publisher, distributor, etc. The University of Chicago Press
Date of publication, distribution, etc. 2011
300 ## - PHYSICAL DESCRIPTION
Extent xv,213p.
Other physical details PB
Dimensions 23x15cm.
365 ## - TRADE PRICE
Price type code QSJW-25055
Price amount ₹1159.10
Currency code ₹
Unit of pricing ₹1635.00
Price effective from 27-01-2026
520 ## - SUMMARY, ETC.
Summary, etc. In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise.<br/>Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech's improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech's science and business, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits.<br/>"Genentech" tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Business History
9 (RLIN) 254895
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biotechnology Industry
9 (RLIN) 254896
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Book
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Date acquired Source of acquisition Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Cost, replacement price Price effective from Koha item type
    Dewey Decimal Classification     General St Aloysius Engineering Library St Aloysius Engineering Library 02/10/2026 amazon.in 1159.10   338.76 HUGG SE000225 02/14/2026 1635.00 01/27/2026 Book